Candida parapsilosis candidaemia in a neonatal unit over 7 years: A case series study

BMJ Open

Volumn 2, Issue 4, 2012, Pages

  Miranda, Lourdes Das Neves ^a   Rodrigues, Eliete C A ^a   Costa, Silvia F ^a   Van Der Heijden, Inneke Marie ^a   Dantas, Kátia C ^a   Lobo, Renata D ^a   Basso, Mariusa ^a   Varkulja, Gláucia F ^a   Krebs, Vera Lúcia Jornada ^a   Gibelli, Maria Augusta Bento Cicaroni ^a   Criado, Paulo R ^a   Levin, Anna Sara ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT;

ARTICLE; BLOOD CULTURE; BRAZIL; CANDIDA PARAPSILOSIS; CANDIDEMIA; CENTRAL VENOUS CATHETER; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; EPIDEMIC; FEMALE; HEALTH CARE PERSONNEL; HOSPITAL ADMISSION; HUMAN; INFECTION CONTROL; LOW BIRTH WEIGHT; MALE; MOLECULAR TYPING; MORBIDITY; NEWBORN; NEWBORN DISEASE; NEWBORN INTENSIVE CARE; NEWBORN MORTALITY; OBSERVATIONAL STUDY; RETROSPECTIVE STUDY; TERTIARY HEALTH CARE; TOTAL PARENTERAL NUTRITION;

EID: 84865118935     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2012-000992     Document Type: Article

References (38)

1. Stoll BJ, Hansen NI, Adams-Chapman I, et al. Neurodevelopmental and growth impairment among extremely low-birthweight infants with neonatal infection. JAMA 2004;292:2357-65.
2. Benjamin D Jr, DeLong E, Cotten C, et al. Mortality following blood culture in premature infants: increased with Gram-negative bacteremia and candidemia, but not Gram-positive bacteremia. J Perinatol 2004;24:175-80.
3. Makhoul I, Sujov P, Smolkin T, et al. Pathogen-specific early mortality in very low birth weight infants with late onset sepsis: a national survey. Clin Infect Dis 2005;40:218-24.
4. Benjamin DK Jr, Stoll BJ, Fanaroff AA, et al. Neonatal candidiasis among extremely low birth weight infants: risk factors, mortality rates, and neurodevelopmental outcomes at 18 to 22 months. Pediatrics 2006;117:84-92.
5. Zaoutis TE, Heydon K, Localio R, et al. Outcomes attributable to neonatal candidiasis. Clin Inf Dis 2007;44:1187-93.
6. Rodriguez D, Almirante B, Park BJ, et al. Candidemia in Neonatal Intensive Care Units Barcelona, Spain. Pediatr Infect Dis J 2006;25:224-9.
7. Kossoff EH, Buescher ES, Karlowicz MG. Candidemia in a neonatal intensive care unit: trends during fifteen years and clinical features of 111 cases. Pediatr Infect Dis J 1998;17:504-8.
8. Al-Sweih N, Khan Z, Khan S, et al. Neonatal candidaemia in Kuwait: a 12-year study of risk factors, species spectrum and antifungal susceptibility. Mycoses 2008;52:518-23.
9. Blyth CC, Chen SCA, Slavin MA, et al. Not just little adults: candidemia epidemiology, molecular characterization, and antifungal susceptibility in neonatal and pediatric patients. Pediatrics 2009;123:1360-8.
10. Lupetti A, Tavanti A, Davini P, et al. Horizontal transmission of Candida parapsilosis candidemia in a neonatal intensive care unit. J Clin Microbiol 2002;40:2363-9.
11. Benjamin DK Jr, Stoll BJ, Gantz MG, et al. Neonatal candidiasis: epidemiology, risk factors, and clinical judgment. Pediatrics 2010;126:865-73.
12. Feja KN, Wu F, Roberts K, et al. Risk factors for candidemia in critically ill infants: a matched case-control study. J Pediatr 2005;147:156-61.
13. Saiman L, Ludington E, Pfaller M, et al . Risk factors for candidemia in NICU patients. Pediatr Infect Dis J 2000;19:319-24.
14. Shetty SS, Harrison LH, Hajjeh RA, et al. Determining risk factors for candidemia among newborn infants from population-based surveillance Baltimore, Maryland, 1998-2000. Pediatr Infect Dis J 2005;24:601-4.
15. El-Mohandes AE, Johnson-Robbins L, Keiser JF, et al. Incidence of Candida parapsilosis colonization in an intensive care nursery population and its association with invasive fungal disease. Pediatr Infect Dis J 1994;13:520-4.
16. Brito LR, Guimarães T, Nucci M. Clinical and microbiological aspects of candidemia due to Candida parapsilosis in Brazilian tertiary care hospitals. Med Mycol 2006;44:261-6.
17. Medrano DJA, Brilhante RSN, Cordeiro RA, et al. Candidemia in a brazilina hospital: the importance of Candida parapsilosis. Rev Inst Med Trop S Paulo 2006;48:17-20.
18. Silva CLP, Santos RMR, Colombo AL. Cluster of Candida parapsilosis primary bloodstream infection in a neonatal intensive care unit. Braz J Infect Dis 2001;5:32-6.
19. Apgar V. A proposal for a new method of evaluation of the newborn infant. Curr Res Anesth Analg 1953;32:260-7.
20. Miranda LN, van der Heijden IM, Costa SF, et al. Candida colonisation as a source for candidaemia. J Hosp Infect 2009;72:9-16.
21. Odds FC, Bernaerts R. CHROMagar Candida, a new differential medium for presumptive identification of clinically important Candida species. J Clin Microbiol 1994;32:1923-9.
22. Gutierrez J, Lozano C, Coronilla J, et al. Evaluation of the ABT 32 C, automicrobic system and API 20 C using clinical yeast isolates. Ann Biol Clin 1994;50:443-6.
23. Lacaz CS. Tratado de micologia médica lacaz. 9a edn. São Paulo: Sarvier, 2002: 618-38.
24. White TJ, Bruns TD, Lee SB, et al. Amplification and direct sequencing of fungal ribosomal RNA genes for phylogenetics. In: Innis MA, Gelfand DH, Sninsky JJ, White TJ. PCR protocols: a guide to methods and applications. San Diego: Academic Press, 1990:315-22.
25. Yong PVC, Chong PP, Lau LY, et al. Molecular identification of Candida orthopsilosis isolated from blood culture. Mycopathologia 2008;165:81-7.
26. Shin JH, Shin DH, Song JW, et al. Electrophoretic karyotype analysis of sequential Candida parapsilosis isolates from patients with persistent or recurrent fungemia. J Clin Microbiol 2001;39:1258-63.
27. Chen KW, Lo HJ, Lin YH, et al. Comparison of four molecular typing methods to assess genetic relatedness of Candida albicans clinical isolates in Taiwan. J Med Microbiol 2005;54:249-58.
28. Binelli CA, Moretti ML, Assis RS, et al. Investigation of the possible association between nosocomial candiduria and candidaemia. Clin Microbiol Infect 2006;12:538-43.
29. Vrioni G, Matsiota-Bernard P. Molecular typing of Candida isolates from patients hospitalized in an intensive care unit. J Infect 2001;42:50-6.
30. Roilides E, Farmaki E, Evdoridou J, et al. Neonatal candidiasis: analysis of epidemiology, drug susceptibility, and molecular typing of causative isolates. Eur J Clin Microbiol Infect Dis 2004;23:745-50.
31. Giusiano GE, Mangiaterra M, Rojas F, et al. Yeasts species distribution in neonatal intensive care units in northeast Argentina. Mycoses 2004;47:300-3.
32. Sastre JBL, Cotallo GDC, Colomer FB. Neonatal invasive candidiasis: a prospective multicenter study of 118 cases. Am J Perinatol 2003;20:153-63.
33. Karlowicz MG, Hashimoto LN, Kelly RE, et al. Should central venous catheters be removed as soon as candidemia is detected in neonates? Pediatrics 2000;106:E63.
34. Nolla-Salas J, Sitges-Serra A, Leon-Gil C, et al. Candidaemia in non-neutropenic critically ill patients: analysis of prognostic factors and assessment of systemic antifungal therapy: study group of fungal infection in the ICU. Intensive Care Med 1997;23:23-30.
35. Kaufman D, Boyle R, Hazen KC, et al. Fluconazole prophylaxis against fungal colonization and infection in preterm infants. N Engl J Med 2001;345:1660-6.
36. Manzoni P, Arisio R, Mostert M, et al . Prophylactic fluconazole is effective in preventing fungal colonization and fungal systemic infections in preterm neonates: a single-center, 6-year, retrospective cohort study. Pediatrics 2006;117:22-32.
37. Posteraro B, Bruno S, Boccia S, et al. Candida parapsilosis bloodstream infection in pediatric oncologic patients: results of an epidemiologic investigation. Infect Control Hosp Epidemiol 2004;25:641-5.
38. Van Asbeck EC, Huang YC, Markham AN, et al. Candida parapsilosis fungemia in neonates: genotyping results suggest healthcare workers hands as source, and review of published studies. Mycopathologia 2007;164:287-93.